les of the virus "have shown signs of mutation, but there is no evidence this has led to more severe disease." According to Reuters, "Scientists at Scripps Research this month found that by April the mutated virus accounted for some 65% of cases submitted from around the world to a major database." Scientists

tential of genetic studies conducted in conjunction with the braining imaging, the team reached out to include Nicholas Schork, a genetics expert at Scripps Research. In deciding a first target, the group decided to focus on a gene known as MECP2 because it plays major roles in controlling brain development. Pas